MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Treatment"

  • 2026 International Congress

    Efficacy of Rapid-Succession “Flash Song” Music Therapy on Cognitive and Behavioral Symptoms in Outpatients with Juvenile Huntington’s Disease

    A. Gangadhar, Y. Dayma (Pune, India)

    Objective: To evaluate the clinical feasibility and efficacy of a novel, rapid-succession music therapy intervention ("Flash Song Therapy") on cognitive function, behavioral symptoms, and quality…
  • 2026 International Congress

    PPAR-γ-dependent Neuroprotection by Ferulic acid improves Motor deficits in 3-nitropropionic acid model of Huntington’s disease in rats

    N. Singh, V. Singh (bathinda, India)

    Objective: This study investigates the neuroprotective role of FA in  3-nitropropionic acid (3-NP) model of HD through PPAR-γ–mediated mechanisms. Background: Huntington disease (HD) is a…
  • 2026 International Congress

    Effectiveness and Safety of Deutetrabenazine in Chinese Patients with Huntington’s Disease-associated Chorea: A Multicenter Phase 4 Study

    Y. Cheng, Y. Huang, J. Ma, J. Yin, X. Dan, J. Qu, Y. Li, G. Zhang, KT. Ustundag, AP. Levin, R. Ribalov, H. Xie, R. Eshet, M. Zeygarnik, J. Wang, H. Shang (Chengdu, China)

    Objective: To evaluate the effectiveness and safety of deutetrabenazine (DTBZ) in Chinese patients with Huntington’s Disease (HD)-associated chorea. Background: Chorea is a key symptom of…
  • 2026 International Congress

    Perception of Early-Intervention Therapies and Clinically Meaningful Delays in Huntington’s Disease Onset and Progression: The Pre-HDBOI Study

    A. Toumadj, I. Rodriguez-Santana, C. Mighiu, A. Arnesen, B. Balas (Lexington, USA)

    Objective: To characterize willingness among people with premanifest Huntington’s disease (PwPHD) to consider early-intervention therapies if available, the minimally acceptable delay in HD onset/progression, and…
  • 2026 International Congress

    Antidepressants in Huntington’s Disease: A Meta Analysis of Mood and Motor Outcomes with Placebo-controlled Trials

    J. Patino, J. Pitton Rissardo, A. Fornari Caprara, A. Mcgarry, I. Walker, N. Rocha, A. Duker, E. Furr Stimming (Cincinnati, USA)

    Objective: To evaluate the efficacy of antidepressants for depression in Huntington’s disease (HD). Background: Depression is highly prevalent in HD. Despite frequent clinical use of…
  • 2026 International Congress

    Efficacy and Adverse Events of Tetrabenazine, Deutetrabenazine, and Valbenazine in Huntington’s Disease

    J. Patino, J. Pitton Rissardo, A. Fornari Caprara, A. Mcgarry, I. Walker, N. Rocha, A. Duker, E. Furr Stimming (Cincinnati, USA)

    Objective: To compare the efficacy and safety of tetrabenazine, deutetrabenazine, and valbenazine for chorea and neuropsychiatric outcomes in Huntington’s disease (HD). Background: Vesicular monoamine transporter…
  • 2026 International Congress

    The Impact of Insurance on Delivery of Huntington’s Care at an HDSA Center of Excellence

    D. Okine, L. Shammas, M. Tobar, P. Perez, A. Mendizabal (Los Angeles, USA)

    Objective: To determine the association between health insurance and Huntington’s Disease (HD) time to diagnosis, delays in access to specialty care, and HD specific clinical…
  • 2026 International Congress

    Stimulation-Level Sweet-Spot and Connectivity Analysis of Pallidal DBS in Huntington’s Disease

    M. Borrell-Pichot, G. Olmedo-Saura, A. Puig-Davi, C. Franch-Marti, S. Martínez-Horta, R. Rodríguez-Rodríguez, JA. Aibar-Duran, R. Martínez-Fernández, B. Pascual-Sedano, J. Kulisevsky, J. Pérez-Pérez, I. Aracil-Bolaños (Barcelona, Spain)

    Objective: To assess clinical outcomes and identify stimulation and structural connectivity patterns associated with motor improvement in Huntington’s Disease (HD) patients undergoing DBS. Background: DBS…
  • 2026 International Congress

    Late onset chorea secondary to antiphospholipid syndrome with radiological correlation on brain FDG-PET: a case report.

    A. Bonilla Tena, G. Lafuente Gómez, A. Contreras Chicote, B. Casa Fages, J. Pérez Sánchez, E. Luque Buzo, V. Pérez Olmo, F. Grandas Pérez (Madrid, Spain)

    Objective: To describe chorea as the initial manifestation of antiphospholipid syndrome (APS) and its radiological correlation on brain FDG-PET as an autoimmune movement disorder. Background:…
  • 2026 International Congress

    Patient and Caregiver Perspectives on Patient Burden of Huntington Disease Chorea and the Real‑World Impact of Deutetrabenazine Treatment

    D. Claassen, W A. Dalrymple, P. Gandhi, D. Klakotskaia, M. Konings, H. Moore, K. Anderson (Nashville, USA)

    Objective: To evaluate self- and caregiver-reported patient burden of Huntington disease (HD) chorea and the impact of deutetrabenazine (DTBZ) treatment on symptom management, quality of…
  • 1
  • 2
  • 3
  • …
  • 12
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley